Momelotinib (CYT387) is a potent JAK1/JAK2 inhibitor. It affects the JAK/STAT signaling pathway by binding to the kinase domain, effectively suppressing tumor cell proliferation, cytokine signaling, and cancer chemoresistance.
Momelotinib (CYT387) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Momelotinib (CYT387) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.